Critical Outcome Technologies (TSXV: COT) CEO: “We’re a True Development Company with a Pipeline of Products Founded on a Platform Technology”

Published:

January 26, 2017

Reading time: Less than 1 min.

Critical Outcome Technologies is advancing targeted therapies for cancer treatment

In this interview with SmallCapPower at the recent Cantech Investment Conference 2017, Critical Outcome Technologies Inc. (TSXV: COT) CEO Alison Silva talks about how her clinical-stage biotechnology company is advancing innovative and targeted therapies for the treatment of cancer.